Glutamate receptor modulator shows mixed results in depression study

Six weeks of adjunctive treatment with the glutamate receptor modulator basimglurant did not lead to significant improvement over placebo on a primary measure of clinician‐rated depressive symptoms in adults, but did achieve results on patient‐rated secondary measures, a new study has found. The findings led the researchers to conclude that further study of basimglurant's potential in depression treatment should take place.

Source: The Brown University Psychopharmacology Update - October 19, 2016 Category: Psychiatry Tags: What's New in Research Source Type: research